Skip to main content

Bee venom allergy immunotherapy

Recurrent anaphylaxis: case report

This is a preview of subscription content, access via your institution.


  • Williams T, et al. A case of recurrent anaphylaxis to honey bee venom immunotherapy with omalizumab used as a premedication. Internal Medicine Journal 48 (Suppl. 6): 18 (plus poster) abstr. P46, Nov 2018. Available from: URL: [abstract] - Australia

Download references

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bee venom allergy immunotherapy. Reactions Weekly 1732, 82 (2018).

Download citation

  • Published:

  • Issue Date:

  • DOI: